Natera
Trade Natera 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NTRA
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
NTRA Key Statistics
Stock Snapshot
With a market cap of 32.33B, Natera(NTRA) trades at $235.00. The stock has a price-to-earnings ratio of -102.55.
During the trading session on 2025-12-02, Natera(NTRA) shares reached a daily high of $240.18 and a low of $233.77. At a current price of $235.00, the stock is +0.5% higher than the low and still -2.2% under the high.
Trading activity shows a volume of 823.71K, compared to an average daily volume of 1.86M.
The stock's 52-week range extends from a low of $125.38 to a high of $241.28.
The stock's 52-week range extends from a low of $125.38 to a high of $241.28.
NTRA News
Some Natera, Inc. ( ) shareholders may be a little concerned to see that the Lead Independent Director, Roelof Botha, recently sold a substantial US$18m worth o...
Flatiron Health recently announced the integration of Natera's oncology testing portfolio into its OncoEMR platform, enabling electronic ordering and results de...
JPMorgan raised the firm’s price target on Natera (NTRA) to $250 from $240 and keeps an Overweight rating on the shares. The firm updated the company’s model....